Leprosy Treatment Market Scenario Highlighting Major Trends & Development Opportunities until 2026 Including Top Players Novartis International AG., Glaxo Smithcline Pharmaceuticals Ltd., Genetic Pharma, Cadila Pharmaceuticals, Lark Laboratories (UIndia)

Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk factors of leprosy include malnutrition and weak immune system. Leprosy is especially prevalent in low-income countries.

Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/128

Leprosy Treatment Market Outlook

According to the statistics received by the World Health Organization (WHO), from various regions (138 countries), the number of registered cases of leprosy was 176,176 in 2015, that is 0.18 cases per 10 000 people. The number of new cases shows the degree of sustained transmission of the disease. Global statistics illustrate that 203,600 (96%) of fresh leprosy cases were from 22 key countries. Prevalence of high occurrences is a reminder that some areas around the world show high incidences of the disease and experience very high rate of transmission. According to WHO, around 16 million cases of leprosy have been treated in the last two decades. Governing bodies and governments alike are trying to eradicate the presence of the disease on a global scale. Owing to these factors, the leprosy treatment market is expected to grow at substantial rate over the forecast period (2016–2024).

Leprosy Treatment Market Future Outlook: Asia Pacific to be Key Growth Market

Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale. Some of them subsidized the treatment to eradicate the presence of the disease from their countries. Therefore government regulation as well as adoption remains the most important driver of the leprosy treatment market.

Asia Pacific, especially India remains one of the most affected countries. As per the World Health Organization reports, about 59% of the new cases reported were from India. According to stats released by the Leprosy Mission Trust, around 127,000 new occurrences of leprosy were reported from India alone during 2013–2014. Out of these, about 46% were women and children. In India, the prevalence rate according to The Leprosy Mission Trust in the year 2014 was about 0.68 per 10,000 population. The National Leprosy Eradication Programme (NLEP) is one such initiative by the Indian government that aims to eradicate the disease from the country by 2018. Therefore, leprosy treatment market in this region is projected to grow at a considerable rate in the near future.

Key Players in Leprosy Treatment Market:

Companies operating in the leprosy treatment market include;

• Glaxo Smithcline Pharmaceuticals Ltd.
• Systopic Laboratories Pvt. Ltd.
• Acme Pharmaceuticals
• Cadila Pharmaceuticals
• Macleods Pharmaceuticals
• IDPL
• Astra Zeneca Pharma India Ltd.
• Lark Laboratories (UIndia) Ltd.
• Genetic Pharma
• Novartis International AG.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/128

Leprosy Treatment Market Taxonomy:

On the basis of type of leprosy, the global leprosy treatment market is classified into:

• Early and indeterminate leprosy treatment
• Borderline tuberculoid leprosy treatment
• Tuberculoid leprosy treatment
• Borderline leprosy treatment
• Histoid leprosy treatment
• Lepromatous leprosy treatment
• Borderline lepromatous leprosy treatment
• Diffuse leprosy of Lucio and Latapí

On the basis of treatment, the global leprosy treatment market is classified into:

• Multidrug Therapy
• Others

On the basis of type of end user, the global leprosy treatment market is classified into:

• Government
• Hospitals
• Medical Practitioners
• Others

Else place an Inquire before Purchase “Global Leprosy Treatment Market Size, Status and Forecast 2026": https://www.coherentmarketinsights.com/insight/talk-to-analyst/128

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.